1-2 of 2
Udo Bode
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Clinical Trials & Observations
Anja Möricke, Alfred Reiter, Martin Zimmermann, Helmut Gadner, Martin Stanulla, Michael Dördelmann, Lutz Löning, Rita Beier, Wolf-Dieter Ludwig, Richard Ratei, Jochen Harbott, Joachim Boos, Georg Mann, Felix Niggli, Andreas Feldges, Günter Henze, Karl Welte, Jörn-Dirk Beck, Thomas Klingebiel, Charlotte Niemeyer, Felix Zintl, Udo Bode, Christian Urban, Helmut Wehinger, Dietrich Niethammer, Hansjörg Riehm, Martin Schrappe
Journal: Blood
Blood (2008) 111 (9): 4477–4489.
https://doi.org/10.1182/blood-2007-09-112920
Published: 2008
Includes: Supplemental data
Journal Articles

Polychemotherapy in patients with primary CNS lymphoma.

Axel Glasmacher, MD, Hendrik Pels, MD, Christoph Helmstaedter, MD, Martina Deckert, MD, Frank Kroschinsky, MD, Gabriele Schackert, MD, Heinz Reichmann, MD, Gerlinde Egerer, MD, Anthony Ho, MD, Holger Schulz, MD, Andreas Engert, MD, Volker Diehl, MD, Udo Bode, MD, Thomas Klockgether, MD, Uwe Schlegel, MD, Ingo G.H. Schmidt-Wolf, MD
Journal: Blood
Blood (2004) 104 (11): 3304.
https://doi.org/10.1182/blood.V104.11.3304.3304
Published: 2004